For patients diagnosed with high-grade gliomas, the most aggressive form of primary brain cancer, one of the most urgent clinical questions is deceptively simple: who will progress within a year, and who will not? A new study published in Annals of Clinical and Translational Neurology offers what its authors describe as a more powerful answer […]
For patients diagnosed with high-grade gliomas, the most aggressive form of primary brain cancer, one of the most urgent clinical questions is deceptively simple: who will progress within a year, and who...
A new study published in Annals of Clinical and Translational Neurology offers what its authors describe as a more powerful answer […]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
For patients diagnosed with high-grade gliomas, the most aggressive form of primary brain cancer, one of the most urgent clinical questions is deceptively simple: who will progress within a year, and who will not? A new study published in Annals of Clinical and Translational Neurology offers what its authors describe as a more powerful answer […]
Open the app view to save this story, compare related coverage, and continue from the same source.